Antibe Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Antibe Therapeutics's estimated annual revenue is currently $3.6M per year.
- Antibe Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Antibe Therapeutics has 23 Employees.
- Antibe Therapeutics grew their employee count by -4% last year.
Antibe Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | VP Communications | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | Chief Operating Officer | Reveal Email/Phone |
5 | Chief Development Officer | Reveal Email/Phone |
6 | Executive Director Clinical Operations | Reveal Email/Phone |
Antibe Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.7M | 9 | -72% | $39.4M | N/A |
#2 | $0.9M | 11 | -83% | $23.8M | N/A |
#3 | $87.6M | 565 | 6% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $7.8M | 50 | -68% | N/A | N/A |
#6 | $13.5M | 87 | 30% | N/A | N/A |
#7 | $17.8M | 115 | -6% | N/A | N/A |
#8 | $0.9M | 11 | -39% | N/A | N/A |
#9 | $13.6M | 88 | -20% | $86M | N/A |
#10 | $20M | 129 | -12% | N/A | N/A |
What Is Antibe Therapeutics?
Antibe Therapeutics is a publicly traded biotechnology company pursuing a breakthrough advance in the treatment of inflammation. Our drug pipeline addresses major markets in non-addictive management of chronic and post-surgical pain. Antibe's lead drug, now in late Phase 2 trials, is demonstrating unprecedented safety in the treatment of chronic pain, a condition that affects more than 50 million Americans alone. Our second pipeline drug is intended to replace a range of opioids, addressing a vast and pressing public health concern. Our third drug is a safer daily aspirin -- delivering anti-stroke and anti-cancer benefits without damage to the digestive tract.
keywords:N/A
N/A
Total Funding
23
Number of Employees
$3.6M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Antibe Therapeutics News
About Antibe Therapeutics Inc. Antibe is a clinical stage biotechnology company leveraging its proprietary hydrogen sulfide platform to develop...
Other Companies in Toronto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.9M | 23 | -60% | N/A |
#2 | $1.5M | 23 | -28% | $57.4M |
#3 | $4.3M | 23 | 0% | N/A |
#4 | $3.2M | 23 | N/A | N/A |
#5 | $2.3M | 23 | N/A | N/A |